GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (BOM:544067) » Definitions » ROCE %

Innova Captab (BOM:544067) ROCE % : 16.27% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Innova Captab ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Innova Captab's annualized ROCE % for the quarter that ended in Dec. 2024 was 16.27%.


Innova Captab ROCE % Historical Data

The historical data trend for Innova Captab's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innova Captab ROCE % Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROCE %
Get a 7-Day Free Trial 97.81 40.57 41.81 31.29 20.34

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 15.20 14.95 16.70 16.27

Innova Captab ROCE % Calculation

Innova Captab's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=1507.26/( ( (7044.14 - 2775.5) + (13208.81 - 2654.81) )/ 2 )
=1507.26/( (4268.64+10554)/ 2 )
=1507.26/7411.32
=20.34 %

Innova Captab's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=1830.16/( ( (14345.47 - 3097.48) + (0 - 0) )/ 1 )
=1830.16/( ( 11247.99 + 0 )/ 1 )
=1830.16/11247.99
=16.27 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innova Captab  (BOM:544067) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Innova Captab ROCE % Related Terms

Thank you for viewing the detailed overview of Innova Captab's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Innova Captab Business Description

Traded in Other Exchanges
Address
SCO No. 301, Sector 9, Second Floor, Panchkula, HR, IND, 134109
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, and marketing and exports. Company business includes (i) a contract development and manufacturing organization ("CDMO") business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.

Innova Captab Headlines

No Headlines